Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Rusan Pharma: Over 30 years of specializing in the treatment of Addiction and Pain Management.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

DEVELOPMENTS

6 Drugs in Development

6 Drugs in Development

DIGITAL CONTENT

3 NEWS #PharmaBuzz

media
3 NEWS #PharmaBuzz

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

6DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: Sonlicromanol, Kh-176, Jcu3o35rds, 1541170-75-5, (2s)-6-hydroxy-2,5,7,8-tetramethyl-n-[(3r)-piperidin-3-yl]-3,4-dihydrochromene-2-carboxamide, 2h-1-benzopyran-2-carboxamide, 3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-n-(3r)-3-piperidinyl-, (2s)-

Molecular Formula

C₁₉H₂₈N₂O₃

Molecular Weight

332.4 g/mol

InChI Key

LZYWLEPSQNXESC-KUHUBIRLSA-N

FDA UNII

JCU3O35RDS

Sonlicromanol is under investigation in clinical trial NCT04165239 (The KHENERGYZE Study).

1 2D Structure

Sonlicromanol

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-6-hydroxy-2,5,7,8-tetramethyl-N-[(3R)-piperidin-3-yl]-3,4-dihydrochromene-2-carboxamide

2.1.2 InChI

InChI=1S/C19H28N2O3/c1-11-12(2)17-15(13(3)16(11)22)7-8-19(4,24-17)18(23)21-14-6-5-9-20-10-14/h14,20,22H,5-10H2,1-4H3,(H,21,23)/t14-,19+/m1/s1

2.1.3 InChI Key

LZYWLEPSQNXESC-KUHUBIRLSA-N

2.1.4 Canonical SMILES

CC1=C(C2=C(CCC(O2)(C)C(=O)NC3CCCNC3)C(=C1O)C)C

2.1.5 Isomeric SMILES

CC1=C(C2=C(CC[C@@](O2)(C)C(=O)N[C@@H]3CCCNC3)C(=C1O)C)C

2.2 Other Identifiers

2.2.1 UNII

JCU3O35RDS

2.3 Synonyms

2.3.1 Depositor-Supplied Synonyms

1. Sonlicromanol

2. Kh-176

3. Jcu3o35rds

4. 1541170-75-5

5. (2s)-6-hydroxy-2,5,7,8-tetramethyl-n-[(3r)-piperidin-3-yl]-3,4-dihydrochromene-2-carboxamide

6. 2h-1-benzopyran-2-carboxamide, 3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-n-(3r)-3-piperidinyl-, (2s)-

7. Unii-jcu3o35rds

8. Sonlicromanol [inn]

9. Chembl4802153

10. Schembl19235721

11. Hy-121577

12. Cs-0082766

13. Q27896123

2.4 Create Date

2014-02-03

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₂₈N₂O₃
Molecular Weight	332.4 g/mol
XLogP3	2.7
Hydrogen Bond Donor Count	3
Hydrogen Bond Acceptor Count	4
Rotatable Bond Count	2
Exact Mass	332.20999276 g/mol
Monoisotopic Mass	332.20999276 g/mol
Topological Polar Surface Area	70.6 Å²
Heavy Atom Count	24
Formal Charge	0
Complexity	472
Isotope Atom Count	0
Defined Atom Stereocenter Count	2
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1